Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.50 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
| ▸ | CTSS | P25774 | 7/20 | 0.46 |
| ▸ | CTSK | P43235 | 6/20 | 0.46 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.45 |
| ▸ | ITGB7 | P26010 | 2/20 | 0.45 |
| ▸ | CTSB | P07858 | 2/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.45 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
| ▸ | PPARA | Q07869 | 3/20 | 0.42 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12241473 | 1.00 | KLK5 (0.50) | KLK5ITGB3ITGA2BCTSSCTSK | |
| SCHEMBL12241482 | 0.89 | ITGB3 (0.57) | ITGB3ITGA2BCTSSCTSKITGA4 | |
| SCHEMBL33526555 | 0.89 | ITGB3 (0.57) | ITGB3ITGA2BCTSSCTSKITGA4 | |
| SCHEMBL763725 | 0.88 | KLK5 (0.50) | KLK5ITGB3ITGA2BCTSSCTSK | |
| SCHEMBL30759356 | 0.87 | KLK5 (0.49) | KLK5ITGB3ITGA2BCTSSCTSK | |
| SCHEMBL8167522 | 0.87 | KLK5 (0.49) | KLK5ITGB3ITGA2BCTSSCTSK | |
| SCHEMBL16644978 | 0.87 | KLK5 (0.49) | KLK5ITGB3ITGA2BCTSSCTSK | |
| SCHEMBL21945131 | 0.87 | KLK5 (0.49) | KLK5ITGB3ITGA2BCTSSCTSK | |
| SCHEMBL4065696 | 0.87 | KLK5 (0.49) | KLK5ITGB3ITGA2BCTSSCTSK | |
| SCHEMBL3009608 | 0.87 | KLK5 (0.49) | KLK5ITGB3ITGA2BCTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | KLK5 4677/4885ITGB3 1087/4885ITGA2B 1892/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.